💉 The Deficit Doesn't Know Its Source September 3, 2026 · https://tavi-blog.github.io/the-deficit-doesnt-know-its-source/

Personal trainers are being told, this year, to stop selling weight loss and start selling muscle preservation, because the people walking into gyms now are losing weight faster than any diet program used to manage, and a meaningful share of what comes off is muscle rather than fat. The reason has nothing to do with a new training method. It's a drug. GLP-1 medications create a caloric deficit steep enough that the body starts breaking down lean tissue right alongside fat, sometimes accounting for close to a third or more of total weight lost, and the fitness industry has spent this year scrambling to retrofit itself around that fact. Protein targets are getting written into intake forms, resistance programming twice a week is turning into a baseline rather than an upsell, and recovery and hydration coaching that used to be an afterthought for anyone chasing a smaller number on the scale is now framed as the whole point.

I read the coverage of this shift and had the specific, slightly bitter recognition of watching an industry rediscover something the hard way that I learned by accident, with no drug involved. I once dropped a large amount of weight through calorie restriction alone, no training, because restriction was the only lever I understood at the time. What came off wasn't fat specifically. It was mass, indiscriminately, and what I was left with at the bottom of that cut was a smaller, softer version of the body I started with, not a leaner one. Nobody had explained to me that a caloric deficit doesn't know or care what it's removing unless you give it a reason to spare muscle, and the only reason a body respects is a training stimulus telling it that tissue is still in use. I found that out the slow way, by getting the outcome wrong once.

The GLP-1 population is arriving at the identical mechanism from a completely different direction, and it's worth taking seriously that the two situations aren't actually the same in degree. A self-directed crash diet is bounded by how much suffering a person will tolerate before they quit; most people, myself included at the time, cave long before the deficit gets severe enough to be genuinely dangerous. An injection doesn't get tired. It suppresses appetite chemically, for months at a stretch, at a magnitude that self-discipline alone rarely produces, which is exactly why the muscle loss shows up faster and larger in this group than it typically did in the diet-book era. That's not a reason to wave off the industry's pivot as opportunism dressed up as new expertise. Trainers coaching this population are managing a more aggressive version of a problem I only ever inflicted on myself in a milder form, and the professional oversight actually matters more here than it would for someone titrating their own calorie count by hand.

What doesn't change is the fix, and that's the part I keep sitting with. The protocol now being rolled out to millions of people on a prescription is protein as the number you actually track, resistance training as the non-negotiable, and everything else held loosely enough to sustain for as long as the deficit runs. That's the exact shape of the plan I built for myself off of trial, error, and a fair amount of research, back when nobody selling fitness content had much reason to make the boring version sound urgent. The market for "eat at a deficit and hope for the best" was fine for years, right up until a drug arrived that made the downside of skipping the boring part impossible to ignore in a population large enough to build a business around.

I don't think it's a coincidence that the retraining only happened once there was a large, drug-paying population attached to the risk. Nobody retooled an entire coaching industry around protein and resistance training for the person quietly restricting their way through a New Year's resolution, even though that person was losing exactly the same percentage of lean mass, just more slowly and with less money on the table. The mechanism was always identical. What changed was who was footing the bill for getting it wrong, and an industry that had spent years treating muscle preservation as a niche interest for people who already lift found its urgency the moment a pharmaceutical company created millions of customers with the same problem I had, minus the years it took me to work out why the number on the scale wasn't the number that mattered.